Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Kite, a Gilead Company

Kite and Appia Bio Announce Collaboration to Research and Develop Allogeneic Cell Therapies for Cancer
From Kite, a Gilead Company
Via Business Wire
Tickers GILD
BioNTech Completes Acquisition of Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, Maryland
From Kite, a Gilead Company
Via Business Wire
Tickers BNTX GILD
Longer-term Data for Kite’s Yescarta® in Relapsed or Refractory Follicular Lymphoma Demonstrate Substantial Survival Improvement Over Current Therapies in Comparative Analysis
From Kite, a Gilead Company
Via Business Wire
Tickers GILD
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.